IL-9-dependent interstitial macrophage function in the allergic lung
过敏性肺中 IL-9 依赖性间质巨噬细胞功能
基本信息
- 批准号:10741356
- 负责人:
- 金额:$ 46.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAdoptive TransferAffectAllergensAllergicAllergic DiseaseAllergic inflammationAlveolar MacrophagesArginineAsthmaAttenuatedBindingCellsChronic DiseaseCost of IllnessDataData SetDendritic CellsDevelopmentDiseaseEnvironmentEnzymesFundingGene ExpressionGene Expression RegulationGenerationsGenesGoalsGrantHealthHealth Care CostsHeterogeneityHigh-Throughput Nucleotide SequencingITGAX geneImmuneInflammationInflammatoryInterleukin-2Interleukin-9LungLymphoid CellMacrophageMediatingMetabolicMetabolic PathwayMucous MembraneMusMutant Strains MiceOrganPathway interactionsPhenotypePolyaminesPopulationProcessProductivityPyroglyphidaeRegulationSignal TransductionSmall Interfering RNASortingT-LymphocyteTherapeuticUnited StatesWorkallergic airway inflammationallergic responsearginaseasthmatic patientautocrinecell typeconditional mutantcytokinein vivointerstitialmast cellmonocytenanoparticlenovelpulmonary functionrecruitresponsesingle-cell RNA sequencingtherapeutic targettranscription factor
项目摘要
PROJECT SUMMARY / ABSTRACT: IL-9-dependent interstitial macrophage function in the allergic lung
Despite IL-9 functioning as a pleiotropic cytokine in mucosal environments, the IL-9 responsive cell repertoire is
still not well defined. In a thorough study to identify IL-9-responsive cells, we found that IL-9 mediates pro-allergic
activities by targeting lung macrophages. IL-9 inhibits alveolar macrophage expansion and promotes recruitment
of monocytes that develop into CD11c+/- interstitial macrophage populations. Interstitial macrophages are
required for IL-9-dependent allergic responses. Mechanistically, IL-9 affects the function of lung macrophages
by inducing Arg1 activity. Adoptive transfer of Arg1+ lung macrophages but not Arg1- lung macrophages can
recover allergic inflammation that is lost in Il9r-/- mice. In parallel, the elevated expression of IL-9, IL-9R, and
Arg1 is correlated with disease in asthma patients. Thus, our studies uncover an IL-9/macrophage/Arg1 axis as
a potential therapeutic target for allergic airway inflammation. In this renewal application we will leverage single
cell RNA-seq datasets to further define the interstitial macrophage population that displays pro-allergic function.
We will determine the IL-9-dependent pathways that lead to changes in macrophage gene expression. Finally,
we will determine how Arg1-dependent metabolic pathways impact intrinsic gene expression in macrophages.
Together, these studies will establish a detailed understanding of macrophage function in the allergic lung and
identify pathways that can be explored for therapeutic value.
项目总结/摘要:过敏性肺中的IL-9依赖性间质巨噬细胞功能
尽管IL-9在粘膜环境中起多效性细胞因子的作用,但IL-9应答细胞库是
还没有很好的定义。在一项鉴定IL-9应答细胞的全面研究中,我们发现IL-9介导促过敏反应,
活性靶向肺巨噬细胞。IL-9抑制肺泡巨噬细胞扩张并促进募集
单核细胞发育成CD 11 c +/-间质巨噬细胞群。间质巨噬细胞
这是IL-9依赖性过敏反应所必需的。IL-9影响肺巨噬细胞的功能
通过诱导Arg 1活性。Arg 1+肺巨噬细胞而非Arg 1-肺巨噬细胞的连续转移可
恢复在Il 9 r-/-小鼠中丢失的过敏性炎症。与此同时,IL-9、IL-9 R和IL-10的表达升高,
Arg 1与哮喘患者的疾病相关。因此,我们的研究揭示了IL-9/巨噬细胞/Arg 1轴,
过敏性气道炎症的潜在治疗靶点。在此更新应用程序中,我们将利用单个
细胞RNA-seq数据集,以进一步定义显示促过敏功能的间质巨噬细胞群体。
我们将确定导致巨噬细胞基因表达变化的IL-9依赖性途径。最后,
我们将确定Arg 1依赖的代谢途径如何影响巨噬细胞中的内在基因表达。
总之,这些研究将建立对过敏性肺中巨噬细胞功能的详细了解,
确定可以探索治疗价值的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK H KAPLAN其他文献
MARK H KAPLAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK H KAPLAN', 18)}}的其他基金
Granzyme A-secreting T cells in allergic inflammation
过敏性炎症中粒酶 A 分泌 T 细胞
- 批准号:
8869766 - 财政年份:2015
- 资助金额:
$ 46.11万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 46.11万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 46.11万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 46.11万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 46.11万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 46.11万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 46.11万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 46.11万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 46.11万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 46.11万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 46.11万 - 项目类别: